Melatonin Dosing for Adult Sleep Onset
Start with 3 mg of immediate-release melatonin taken 1.5-2 hours before your desired bedtime, and if needed after at least one week, titrate upward in 3 mg increments to a maximum of 15 mg, though doses above 10 mg risk receptor desensitization and reduced effectiveness. 1
Critical Context: When NOT to Use Melatonin
- The American Academy of Sleep Medicine explicitly recommends against using melatonin for chronic insomnia in adults, as trials using 2 mg doses showed no clinically significant benefit for sleep onset or maintenance, with benefits approximately equal to harms based on very low quality evidence. 2, 1
- If you have chronic insomnia (difficulty falling or staying asleep for ≥3 months), consider FDA-approved hypnotics or cognitive behavioral therapy for insomnia (CBT-I) instead. 2, 1
Evidence-Based Dosing Algorithm
Starting Dose
- Begin with 3 mg immediate-release melatonin administered 1.5-2 hours before your desired bedtime (not at bedtime itself). 1
- The timing is critical: administration at 6-7 PM (1-2 hours before an 8-9 PM bedtime) optimizes circadian rhythm regulation. 1, 3
- Lower doses (0.3-3 mg) may actually be more effective than higher doses because receptor saturation and desensitization occur at doses ≥10 mg. 1
Titration Schedule
- Continue the initial 3 mg dose for at least 7 days before assessing efficacy. 1
- If inadequate response after one week, increase by 3 mg increments. 1
- The dose-response relationship peaks at approximately 4 mg/day for optimal sleep onset latency reduction and total sleep time increase. 4
Maximum Dose
- Do not exceed 15 mg as a maximum dose, though routine use above 10 mg is discouraged due to receptor desensitization. 1
- Doses above 10 mg reduce effectiveness and may cause hypothermia and prolonged daytime melatonin elevation. 1, 5
Special Circumstances
Delayed Sleep-Wake Phase Disorder (DSWPD)
- Use 5 mg melatonin timed between 19:00-21:00 (7-9 PM) for at least 28 days. 2
- This represents the one condition where melatonin has demonstrated clinically meaningful benefit, reducing sleep latency by 38-44 minutes and increasing total sleep time by 41-56 minutes. 2
Older Adults (>55 years)
- Consider starting with lower physiologic doses (0.3 mg) as this can restore sleep efficiency to normal levels by elevating plasma melatonin to the nocturnal range. 5
- Alternatively, 5 mg has been shown effective in older adults for both nighttime and daytime sleep episodes, primarily by increasing Stage 2 NREM sleep duration. 6
- Prolonged-release formulations at 2 mg have shown some benefit in elderly patients, though evidence quality is low. 1
Realistic Expectations
- Melatonin reduces sleep onset latency by approximately 28-42 minutes. 1
- Total sleep time increases by approximately 1.8-2.6 hours in responsive populations. 1
- Effects are most pronounced when administered 2-4 hours before habitual bedtime rather than immediately before sleep. 4, 7
Critical Safety Warnings
- Use with extreme caution in patients taking warfarin due to potential drug interactions reported to the WHO. 1
- Exercise caution in patients with epilepsy based on case reports of adverse events. 1
- Melatonin is regulated as a dietary supplement in the U.S., not as a medication, raising concerns about purity and dose accuracy. 1
Product Selection
- Choose United States Pharmacopeial Convention (USP) Verified formulations for more reliable dosing and purity, as unregulated supplements may contain variable amounts of melatonin. 1
Common Pitfalls to Avoid
- Do not take melatonin at bedtime—the optimal window is 1.5-2 hours (or even 2-4 hours) before desired sleep onset. 1, 4, 7
- Do not use melatonin as first-line therapy for chronic insomnia; it is ineffective for this indication per AASM guidelines. 2, 1
- Avoid doses above 10 mg routinely, as receptor desensitization paradoxically reduces effectiveness. 1
- Do not expect immediate results; allow at least 7 days (or 28 days for DSWPD) to assess efficacy. 2, 1